2023
DOI: 10.1530/eor-22-0106
|View full text |Cite
|
Sign up to set email alerts
|

Orthopaedic applications of cold physical plasma

Abstract: Cold physical plasma (CPP) technology is of high promise for various medical applications. The interplay of specific components of physical plasma with living cells, tissues and organs on a structural and functional level is of paramount interest with the aim to induce therapeutic effects in a controlled and replicable fashion. In contrast to other medical disciplines such as dermatology and oromaxillofacial surgery, research reports on CPP application in orthopaedics are scarce. The present implementati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 8 publications
(9 citation statements)
references
References 143 publications
0
9
0
Order By: Relevance
“…Additionally, after repeated surgical interventions, CPP was used to support wound healing in this patient case. Recently, its feasibility in orthopaedic surgery has been reviewed and highlighted several promising applications ( 35 ). Particularly remarkable is CPPs effective action against biofilm and multidrug-resistent germs ( 36 , 37 ).…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, after repeated surgical interventions, CPP was used to support wound healing in this patient case. Recently, its feasibility in orthopaedic surgery has been reviewed and highlighted several promising applications ( 35 ). Particularly remarkable is CPPs effective action against biofilm and multidrug-resistent germs ( 36 , 37 ).…”
Section: Discussionmentioning
confidence: 99%
“…First, plasma medicine has been limited to tumour cancers (currently excluding lymphomas and blood cancers), which are heterogeneous in classification, subtyping, and metastases [73,74]. Although CP has shown efficacy in osteosarcoma in vitro and in vivo, direct CP treatment is extremely invasive, and the use of less-invasive injectable PAL requires further research before clinical translation [75]. Fortuitously, CP treatment of blood from leukaemia patients has shown evidence that cancerous cells can be killed without adversely affecting haematological profiles [76].…”
Section: Cancermentioning
confidence: 99%
“…First, plasma medicine has been limited to tumour cancers (currently excluding lymphomas and blood cancers), which are heterogeneous in classification, subtyping, and metastases [88,89]. Although CP has shown efficacy in osteosarcoma in vitro and in vivo, direct CP treatment is extremely invasive, and the use of less-invasive injectable PAL requires further research before clinical translation [90]. Fortuitously, CP treatment of blood from leukaemia patients has shown evidence that cancerous cells can be killed without adversely affecting haematological profiles [91].…”
Section: Cancermentioning
confidence: 99%